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Abstract
Background In the UK, altruism has featured explicitly as an
underpinning principle for biobanking. However, conceptualizing
donation as altruistic downplays the role of reciprocity and per-
sonal or family beneﬁt.
Objective To investigate how biosample donors talk about their
donation and whether they regard samples as ‘gifts’.
Methods In this qualitative study, 21 people, both healthy volun-
teers and people with health conditions, who had been invited to
give biosamples took part in semi-structured narrative interviews.
The data were transcribed verbatim and thematically analysed.
Results The term ‘gift’ was considered appropriate by some, but it
also evoked puzzlement, especially in relation to ‘waste’ material (e.g.
urine or tumour samples). Whilst ‘giving’ or ‘donating’ were com-
monly mentioned, the noun ‘gift’ signiﬁed something more special and
deliberate. Analysis suggested biosamples could be interpreted as gifts
in several diﬀerent ways, including unreserved gift; reciprocal gift; col-
lective gift; unwanted/low-value gift; and gift as an exaggeration.
Discussion and conclusions Although people describe a network
of exchange consistent with anthropological understandings of gift
relationships, lay (and biomedical) understandings of the term
‘gift’ may diﬀer from anthropological deﬁnitions. For donors (and
researchers), value is attached to the information derived from the
sample, rather than the sample itself. Consequently, when asking
people for biosamples, we should avoid using the term ‘gift’.
Acknowledging the value of participation and the information the
sample holds may mean more to potential donors.
Introduction
Biobanking, governance and consent
In 1999, a UK public inquiry followed the dis-
covery that a pathologist at Liverpool’s Alder
Hey children’s hospital had retained organs for
research without parental consent. This led to
the UK Human Tissue Act 2004 and the regu-
latory Human Tissue Authority from 2006.
Media analysis suggests that reporting of such
incidents created a climate of public horror,
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with images of fragmented bodies and ‘stolen
hearts’1 (p 38–39):
The organ retention scandal was exceptionally
powerful in its designation of villains, victims,
heroes, and its organization of the ‘proper’
responses to events and actions, in particular by
polarizing the interests of the medical/scientiﬁc
community and the lay community. . ... Politi-
cians during the scandal aimed to align them-
selves with the apparent victims, and were
notable for their unwillingness to defend the
medical agenda and their readiness to take the
part of presumed ‘public opinion’ as it appeared
to them to be represented in media reports.
Such reporting presumes that all body parts
are special and that suspicion of and resistance
to using human tissue in medical research are
widespread. In bioethics and social science lit-
eratures, a discourse of ‘social unease’ about
biosamples has predominated,2 in which bodily
integrity, dignity, personhood and autonomy
are set against a rising tide of commodiﬁcation
and capitalist exploitation.3,4 Waldby and
Mitchell5 (p 24) argue that Titmuss’6 view of
voluntary blood donation as ‘intrinsically ethi-
cal. . .has simply rendered the body an open
source of free biological material for commer-
cial use’. Some have therefore argued for
retention of individual property rights over
biosamples, potentially resulting in paying par-
ticipants royalties or proﬁt shares.7
The issue is further complicated by develop-
ments in genetics and increasingly widespread
storage of DNA samples, generating public
concerns about a surveillance society, and
other fears such as genetic manipulation and
cloning.8–10
Biobanks are repositories of biosamples,
which are used to conduct research into the
prevention, diagnosis and treatment of a range
of diseases. The question of biobank regulation
and the relationship between donors and
research has generated much ethical and socio-
legal debate.11–15 This ﬁts within a wider litera-
ture around trust and the feasibility (or not) of
fully informed consent.16 This particularly
aﬀects biobanking given the long-term nature
of sample storage and the diﬃculty of antic-
ipating every possible future use, coupled with
growing pressure from funders to share
research data as a public good.17
However, much of this is either theoretical
debate or single legal case analysis rather
than empirical work to gauge how far ‘social
unease’ really represents public views.2 Empir-
ical studies of the views and reasoning of
people who have contributed samples for
research have identiﬁed generally supportive
and willing attitudes.18–20 Donors may have
concerns, but there is a mismatch between
what matters to them and researchers’
‘remarkable ﬁxation on the consent issue’21
(p 440), which, to some extent, is dictated by
the regulatory system in which they work. In
fact, the evidence on what matters to donors
is conﬂicting and hard to interpret. From
questionnaire survey research, Hoeyer21 sug-
gests we can identify ‘few messages other
than “people feel diﬀerently about these
issues”’, although he oﬀers ‘a few general
insights for cautious contemplation’21 (p 437),
including:
1. Views vary by the type of tissue asked for
and the position of the donors (e.g. whether
they themselves have an illness which could
beneﬁt from the research)
2. Many donors are interested in accessing
research results, particularly those relevant
to their own health
3. Only a minority would never participate in
biobank research
4. Most think the donor should have a say
concerning retention of tissue, but it is
unclear whether people prefer broad or spe-
ciﬁc consent
5. A majority accept commercial access to
public biobanks if it helps science
Hoeyer’s review of qualitative studies21 of
potential and actual donors suggests these oﬀer
more consistent results than surveys, especially
that informed consent is a low priority, and
donors rarely read, recall or use the informa-
tion they receive. Consent procedures may even
be interpreted as protecting research institu-
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tions rather than participants. Motivations for
participation often seem to concern mutual
beneﬁt and reciprocity more than ‘purely’
altruistic considerations.
A review of sociological evidence22 supports
these ﬁndings, suggesting that trust can help
explain the apparent paradox that people are
aware of risk but remain generally willing to
donate: people know they may be harmed, but
they do not expect to be harmed, because they
trust science, researchers and institutional gov-
ernance. Most people do not see tissue as
‘sacred’ or an intrinsic part of themselves, or
something they own. On the contrary, diseased
tissue may be seen as a ‘foreign and unwelcome
invader’22 (p 801), and other samples just as
waste. The personal information attached to
the sample may have more value than the sam-
ple itself.
Altruism, reciprocity and the gift relationship
Altruism has featured explicitly in the UK as an
underpinning principle for biobanking, rather
than the property rights-based approach.23 For
example, the Nuﬃeld Council on Bioethics24
(p 68) described donating tissue as ‘a gift. . .free
of all claims’ and ‘a voluntary transfer. . .with
no expectation of its return’ – which anthropol-
ogists might consider a misunderstanding of gif-
ting as an exchange relationship based on
mutual obligation.25 Similarly, the UK Medical
Research Council26 (p 3) states unequivocally:
‘Samples of human biological material obtained
for use in research should be treated as gifts’
and when it funded the UK Brain Banks Net-
work thanked donors and their families ‘for
their altruistic donation’.27 When announcing a
new brain imaging study in 2014, UK Biobank
Director Sir Rory Collins was reported as say-
ing: ‘UK Biobank is a remarkable example of
altruism. Participants have got involved not for
themselves, but to improve the health of future
generations’.28
Critiquing what she calls the ‘fallacy of
altruism’, Kanellopoulou23 (p 42) identiﬁes a
shift towards a model of mutual exchange
between donors and researchers. She proposes
a distinction between a free (unconditional)
one-oﬀ gift and a ‘conditional gift’, which
involves the ‘exchange of reciprocal returns
implied by on-going collaborative interaction
and dynamic relations between mutually
engaged parties’23 (p 46). Equally, Haimes and
Whong-Barr29 note that motivation to donate
is not as altruistic as often presumed; there is
an assumption amongst donors of reciprocity
and beneﬁt sharing. They assert that using the
concepts of donation and non-donation is too
simplistic to understand participation in bio-
bank research, which they describe as ‘a highly
varied social process, with multiple meanings’29
(p 152).
Similarly, a European study of public atti-
tudes to biobanks30 (p 9) concludes reciprocity
is an essential principle:
When people donate to a biobank, many think
that this is not a free gift; they participate with
the expectation of getting something in return.
Supporting science and medicine is a strong
incentive. . .At the same time, many people
assume that they will receive insights into their
health status, and they look forward to the possi-
bility of regular health checks with the opportu-
nity of meetings with medical experts.
Tutton’s31 study of blood sample donation
for DNA research in Orkney also found mixed
reasons for taking part. Some participants fore-
grounded helping the genetics researcher and
helping the Orkney community to understand
its history, with no personal expectation of
return. Some anticipated medical research ben-
eﬁts, including genetic insights into Orkney’s
high multiple sclerosis rates. But participants
also valued personal feedback about their
genetic ancestry. Tutton31 concludes that altru-
ism can only partially explain why people give
samples for research. One of the authors of this
paper has argued similarly in relation to clini-
cal trial participation.32
Widdows and Cordell33 argue that we need
to pay attention to wider ‘corporate goods’
which may accrue from biobank research,
which go beyond individual beneﬁts and reci-
procity. The wider public good of improved
health for future generations (and the social
ª 2015 The Authors. Health Expectations Published by John Wiley & Sons Ltd.
Health Expectations, 19, pp.805–816
Biosamples as gifts?, L Locock and A-M R Boylan 807
and economic beneﬁts which may ﬂow from it)
does not directly beneﬁt any single biobank
participant, but collectively beneﬁts us all as
members of society. They suggest we should
not think in terms of individual versus commu-
nity, protecting individual rights ‘against some
faceless mass’33 (p 23), but rather in terms of
respecting whole communities of which we are
all part.
Many discussions around gifts and reciproc-
ity in biobanking cite Titmuss’s study6 compar-
ing UK and US systems of blood donation. He
concluded that the UK system of unpaid all
voluntary donation exempliﬁed a ‘gift relation-
ship’ characterized by ‘creative altruism’ in
which the recipient is anonymous and the
donor expects no immediate or direct personal
reward. Although he also invokes a more
anthropological view of gift giving as an
exchange, and blood donation as an expression
of reciprocal social solidarity, he has been criti-
cized for overemphasizing altruism.32
Whilst many studies allude to Titmuss6 to
frame analysis of people’s accounts of their
motivations and attitudes, few have directly
asked people what they think of biosamples as
gifts. An exception is Dixon-Woods and col-
leagues’ study19 of the attitudes of parents,
whose children have cancer, to tissue samples
as ‘gifts’. They found that the blood donation
‘gift’ model did not match families’ views, and
the samples were not valued by the donors.
Parents consented on condition there was no
risk, pain, or inconvenience to their child.
Using the term ‘gift’ appeared troubling –
rather than persuading family members to con-
sent, it provoked some discomfort, and even
oﬀence. Thus, the term ‘gift’ could undermine
rather than secure the co-operation of potential
donors.
However, these family accounts did demon-
strate some key features of Titmuss’s6 ‘gift rela-
tionship’, particularly tissue banking as a
means of aﬃrming social solidarity with a well-
deﬁned childhood cancer ‘illness community’.
Consent was directed towards helping others in
the interests of common (rather than individ-
ual) good, without expecting reward.
We build on Dixon-Woods and colleagues’
study19 by asking biobanking participants
explicitly about their attitudes to biosamples as
gifts and add to the evidence in several ways.
Firstly, we examine the responses of self-
consenting adults, rather than parents consent-
ing for their children. Secondly, we assess the
responses of healthy volunteers and people
aﬀected by a wider range of conditions.
Finally, we explore how people feel about dif-
ferent types of sample (including urine, blood
and tumour samples).
Methods
Sample and recruitment
Twenty-one people were recruited who had
given biosamples for research or had been
invited and declined. Some had given samples
more than once or had consented on one occa-
sion but declined on another. One had declined
the only time he was asked (for a population
biobank). All were white British. Some were
recruited for us by researchers at speciﬁc bio-
banks; others came from media advertising,
snowballing or word of mouth. The sample
included both healthy volunteers and people
with a health condition (see Table 1). The
research was approved by the Berkshire
Research Ethics Committee (ref: 09/H0505/66).
Data collection, coding and analysis
LL interviewed participants in 2010–11 at
home or elsewhere if preferred. Participants
were initially invited to talk about their bio-
banking experience in their own words, with
little interruption from the interviewer. This
opening question indicated that we were inter-
ested to know how they got involved and why,
what happened when they took part, what
information they remember being given and
how they felt looking back. This was followed
by semi-structured prompting around these
and other topics. Prompts relevant to this
paper included questions around motivations
for taking part, and a speciﬁc question about
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biosamples as gifts. The exact wording of this
question varied depending on the individual
context and what had already been said during
the interview, but a typical formulation would
be ‘Some people describe donating a tissue
sample as being like giving a gift. Do you see
your donation in that way?’ Interviews lasted
approximately an hour; they were video or
audio recorded, transcribed verbatim and anal-
ysed thematically.
Interview transcripts were ﬁrst coded (by
AMB) using NVIVO software and an initial
coding framework developed by both authors
in discussion. This included the full range of
anticipated and emergent themes (e.g. recruit-
ment and information, deciding whether to
donate, experiences of actual donation, feed-
back and communication) and was reﬁned
through constant comparison. We reﬂected on
speciﬁc comments about the diﬀerential value
of samples in response to questions about type
of donation (especially tumour, urine and
blood). We also reﬂected on the links between
attitudes to samples and whether or not the
person was healthy or had an illness. For this
paper, we jointly analysed in more detail the
range of perspectives expressed within the
codes relating to reasons for participating, and
attitudes to the term ‘gift’, paying particular
attention to use of language. Wider ﬁndings
are available on the health information Web-
site healthtalk.org.
Results
General reasons for taking part
Before discussing responses regarding samples
as gifts, we summarize people’s motives for
taking part in biobanking. Consistent with the
literature, they gave a range of reasons. Com-
pared to genetics research or clinical trials,
biobanking oﬀers fewer obvious familial or
personal beneﬁts, especially for healthy volun-
teers; not surprisingly, therefore, ‘altruistic’ or
social motivations were commonly expressed.
However, personal beneﬁts were also noted,
most commonly by people with an illness or
condition, but also by healthy volunteers.
Reasons for taking part included aiding
medical science; improving understanding and
treatment of health and illness for future
patients; gaining potential personal beneﬁts
(e.g. a free health check/information about
one’s health; obtaining better care; aiding the
potential development of a cure for one’s con-
Table 1 Sample characteristics
Participant Type of biobanking Gender and age
01 Cancer and population
biobank
F, 55
02 Cancer M, 58
03 Healthy volunteer,
population biobank
(declined)
M, 43
04 Healthy volunteer,
diabetes biobank
(declined population
biobank)
F, 49
05 Cancer F, 52
06 Healthy volunteer,
population biobank
F, 49
07 Healthy volunteer,
population biobank
and diabetes biobank
F, 52
08 Hepatitis C virus M, 54
09 Motor neurone disease F, 56
10 Hepatitis C virus M, 66
11 Healthy volunteer,
diabetes biobank
(accepted and
declined on different
occasions)
M, 49
12 Motor neurone disease M, 63
13 Motor neurone disease M, 61
14 Healthy volunteer,
stroke study as family
member control and
population biobank
F, 62
15 High-risk pregnancy
and healthy volunteer,
population biobank
F, 45
16 Motor neurone disease M, 54
17 High-risk pregnancy F, 37
18 Hepatitis C virus M, 49
19 Healthy volunteer,
pregnancy biobank
F (age withheld)
20 Healthy volunteer,
population biobank
M, 33
21 Healthy volunteer,
population biobank
F, 44
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dition); intellectual curiosity; and showing grat-
itude to the NHS and previous research partici-
pants for current standards of care and
treatment. One person mentioned a sense of kar-
mic value alongside diﬀuse reciprocity, the
notion that good actions may be repaid by dif-
ferent people across time and across generations,
as part of a general system of neighbourly
behaviour rather than individual reciprocation:
The motive was there: there but for the grace of
God go I. And this kind of karma may come
back and protect me. I know that’s all spooky
nonsense [. . .] At various points in my past I’ve
needed help, and at some point in the future I
may need help (Female, healthy volunteer, popu-
lation biobank)
In addition to beneﬁts reported as initial
motivating factors, people later perceived other
advantages which they said might encourage them
to take part again, including the rapport and sense
of partnership they enjoyed with researchers.
Many viewed the decision to take part in
biobanking as less of a ‘Why?’ and more of a
‘Why not?’ Trust in UK research regulation
was high and biosample donation was seen as
unproblematic. Whilst some wanted to know
how their sample would be protected, several
said they had not read the information leaﬂets
they were given because they were conﬁdent
it would be appropriately handled by the
researchers and safeguarded by regulations.
Biosamples as gifts
We now present ﬁve original interpretations of
biosamples as gifts: unreserved, reciprocal, collec-
tive, unwanted/low-value and exaggerated gift.
‘Gift’ as an appropriate term – the unreserved gift
For most people interviewed, biobanking
seemed simple to do; many were surprised or
puzzled to think there was even a story to tell,
let alone that anyone would be interested to hear
it. Many said they had not considered their
donation as a gift until explicitly questioned
about it, a gift not routinely thought of as such,
but for a few this resonated (see Box 1).
This view seemed more common amongst peo-
ple with a speciﬁc health condition, perhaps reﬂect-
ing the sense of an illness community (a shared
sense of identity with others who experience the
same illness) with future beneﬁciaries of the
research. It is important also to note the point that
a sample may be ‘very easy to give’, although in
the case of the MND biobank taking part included
an option to have a lumbar puncture to donate
spinal ﬂuid. Two of the four people interviewed
with motor neurone disease (MND) had declined
this element of the research as too invasive.
The last of the three quotations in Box 1 is
interesting in the way the respondent moves
from a question about a ‘gift’ to a more mun-
dane verbal form, ‘I’ve given it’. We return to
this point later. Her remark ‘It’s something I
can do’ also relates to other points in her inter-
view where she described research participation
as a way of regaining control when faced by
terminal illness, ‘almost to get back at the dis-
ease’. As she explained:
The thought of just sitting, waiting for the disease
to take over seemed very alien. And so I thought
the only proactive thing that I could do about the
disease was maybe to take part in any research.
Thus, whilst she perceived no direct health
beneﬁt, an alternative form of personal beneﬁt
is evident, in helping her make sense of a dis-
tressing situation.
A reciprocal gift
For some people, the notion of a direct rela-
tionship with past or future beneﬁciaries of
health care and medical research was explicit,
not just in terms of an illness community but
also sometimes one’s own family (see Box 2).
One woman, who did not herself ﬁnd the lan-
guage of gift appropriate, nonetheless identiﬁed
reciprocal exchange at the heart of her motiva-
tion. Her twin brother received a lot of care
including (unsuccessful) experimental surgery.
As a healthy donor to a diabetes biobank, she
felt she was giving back on his behalf. Another
woman recovering from breast cancer felt more
at ease with the language of gift, even though
it had not occurred to her before.
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It is signiﬁcant that breast cancer can have a
genetic component; the potential to help others
in one’s family may therefore temper the sense
of altruism. Note, for example, the force of ‘but’
in the second extract in Box 2 – ‘there is no per-
sonal beneﬁt to you at this time. But of course
we all think about generations to come and our
families’ – implying that even if there is no per-
sonal beneﬁt now there may be later in the form
of familial beneﬁt, alongside wider social beneﬁt.
Note also how her initial deﬁnition of a gift
(because there is no personal beneﬁt) reﬂects the
interpretation of gift in policy documents cited
in the introduction (‘a gift free of all claims’)
rather than an anthropological exchange model.
A man with well-controlled hepatitis C virus
who had often given blood and liver samples
questioned the direction of the gift and high-
lighted the reciprocal importance of research
which might develop a cure during his lifetime.
That’s valuable time that’s being spent on some-
thing very important. And it’s probably as
important to me as it is to the people doing the
research. So who’s getting the gift? Me, or them?
However, although he personally did not
ﬁnd it appropriate for what he described as
‘tissue, odd bits, pints of blood’ (see ‘gift as
exaggeration’ below), he added, ‘I can see
“gift” might resonate with some people. I can’t
oﬀhand think of a better term’.
Collective gift
One woman, musing on the diﬀerence between
the kind of gift relationship involved in blood
donation versus biosamples for research, used a
comparison with the oﬃce whip-round. This
was an isolated but intriguing conceptualization.
I suppose you could regard that [biobanking]
more like a sort of collection for a gift or some-
thing, you know - a collection for a leaving gift
or something in the oﬃce - rather than the per-
sonal gift. (Female healthy volunteer, population
biobank)
This is an interesting representation of the
social distance between donor and recipient,
suggesting both how the ‘gift’ in itself is worth-
less or of low value unless combined with
others’ contributions, and how this in turn
undermines any sense of personal relationship
with eventual beneﬁciaries, speciﬁcally unlike a
blood donation which goes from one person
straight to another.
Unwanted or low-value gift
As noted earlier, many people had never before
considered donated biosamples as gifts. Many
struggled to relate this idea to their own experi-
ence, often laughing or giving humorous
replies. Consistent with the notion of a collec-
tive gift, where one’s own contribution has lit-
tle intrinsic value until combined with others,
some people considered it at best a low-value
or unwanted gift.
I don’t regard that I’m giving it as a gift. Maybe
a free gift? No, I don’t think of it as a gift.
(Female healthy volunteer to both a population
and a diabetes biobank)
A woman who had contributed to a popula-
tion biobank but also gave breast cancer
tumour samples for research agreed with the
Box 1 Biosamples as an unreserved gift
I would say unequivocally, yes. It is, for me personally, a gift, and that’s where I stand (Man with MND)
Yes, it strikes a chord with me that when I give a sample or a donation it is like giving a gift, though it’s
one that I’m very happy to give, and in the case of an extra urine sample, for example, it’s very, very easy
to give (Woman who gave samples both as a healthy volunteer and during high-risk pregnancy)
I suppose it is [a gift] in a sense, really. It’s something I can do, and I feel I have no claim whatsoever over
it, that I’ve given it (Woman with MND)
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idea of participation as a gift, but in relation
to her tumour sample commented:
The alternative is it gets thrown away. Well, if
somebody else can use it. . . You get Christmas
gifts you don’t want, so you recycle them
through the charity shop or something. That’s
the same thing. I know that’s perhaps trivializing
it. But if somebody can get use out of it, why
not?
‘Gift’ as an exaggeration
Underlying many of these responses was a
sense that the use of the word ‘gift’ was over-
stating the value of biosamples, an exaggera-
tion some saw as faintly ridiculous. This view
was particularly associated with tumour and
urine samples, although for some people it
applied equally to blood (see Box 3).
Interestingly, the man with hepatitis C virus
quoted in Box 3 went on to say of his dona-
tions, ‘I suppose it’s my philanthropic side –
and that I’ve found surprisingly rare in other
people, which has surprised me over the years’.
Thus, ‘philanthropy’ resonated with him even
if ‘gift’ did not.
However, others saw blood as something dif-
ferent. This may partly reﬂect the more
invasive nature of donating blood samples,
compared to something which is excreted
or is being removed anyway. Perhaps more
signiﬁcantly, people often found it diﬃcult to
separate blood for research from therapeutic
blood donation in their thinking, which in turn
reveals the special signiﬁcance attached to
blood as a valuable and life-giving substance.
This contrasts with waste products such as
urine or a positively ‘unwelcome invader’ such
as a tumour. An example of this way of think-
ing is given in Box 4.
The example in Box 4 brings us back to the
use of language. Whilst the verbs ‘give’ and
‘donate’ were used readily in people’s talk
about biosamples, the noun ‘gift’ seems to
imply something more special and deliberate,
evoking an image of a gift-wrapped present. As
one healthy volunteer commented, reminding us
of the beneﬁts she derived from participation:
To me giving a gift’s sort of a bigger thing. . ..As
I’ve said before, to me there were some beneﬁts
[laughs] because, you know, you were relaxing all
day. . ..But I mean to me, giving - I mean you go
to your GP and he could say, “Well, I need a
blood sample.” But you wouldn’t say you were
giving him a gift, would you?
Discussion and conclusions
We have explored people’s thoughts about the
concept of donating biosamples as ‘gifts’. We
found that attitudes to donation are ambigu-
ous and this is consistent with previous
research.22 Participants cited several reasons
for donating, often being motivated by multi-
ple factors. The ﬁndings from our qualitative
sample also accord with survey ﬁndings sug-
Box 2 Reciprocal gifts
I like to think that maybe I’m helping future generations overcome some of the problems that we all have.
One of things that the studies always do tell me is that what they’re looking for is not to help me in my
lifetime, because studies take 30, 40 years, you know, to come to fruition, but it’s for, it will help other
people. And I think going back over my life people must have done that for my brother to have those
operations. And I suppose I came to think of it in terms of, “I’ll do my little bit to help”. (Woman,
healthy volunteer)
I hadn’t thought of it in those terms, but, yes, I think it is [a gift], because they’re very keen to stress that
there is no personal beneﬁt to you at this time. But of course we all think about generations to come and
our families, and I would hope that in some way it can contribute to better health and better diagnosis
and treatment for family, you know, generations to come. (Woman who gave samples both as a healthy
volunteer and during breast cancer treatment)
812 Biosamples as gifts?, L Locock and A-M R Boylan
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gesting that people may not ﬁnd biosample
donation as ethically troubling as some ethi-
cists presume; for many the donation of
‘waste’ products (e.g. tumour or urine) evokes
little concern, conﬁrming previous ﬁndings
that people trust research regulation and per-
ceive few actual risks.22
Equally, our conceptualization of reciprocal
gifts and especially the collective gift adds weight
to Widdows and Cordell’s33 notion of corporate
goods, which go beyond individual beneﬁts and
reciprocity. Our participants acknowledge a
value in donating even ‘low-value/unwanted
gifts’ for our collective social good.
For this study, it proved very diﬃcult to
recruit people from ethnic minority communi-
ties and also those who refused to take part in
biobanking. As people who had consented to
donate samples felt they had little to tell, those
who declined would presumably ﬁnd it even
harder to see what they could contribute in an
interview. We interviewed one man who
declined primarily because of concerns about
data protection. It would be valuable to have
more perspectives from people who decline
donation.
Our ﬁndings reveal a range of previously
unexplored perspectives on the notion of bio-
samples as gifts. Consistent with Dixon-Woods
et al.,19 our more diverse sample of self-consent-
ing adults indicates that the word itself resonates
with some (especially those living with an ill-
ness), but not with others (both healthy volun-
teers and those living with an illness), and that
all samples as gifts are not considered equal.
However, this is generally not because they
regard the sample as some intrinsically impor-
tant part of themselves, rather it is seen as some-
thing minor and trivial; easy to give; something
potentially beneﬁtting themselves and others;
and which aﬃrms social solidarity through dif-
fuse or asynchronous reciprocity. Even if they
invoke concepts and language which could be
seen as consistent with anthropological under-
standings of an exchange network, people are
commonly sceptical of the actual word ‘gift’,
seeing it as an overstatement, and tend to adopt
a lay deﬁnition (similar to the biomedical dis-
course) of a ‘gift free of all claims’ without feel-
ing they are creating obligations in return. Nor
do they seem to expect any continuing relation-
ship with the biobank.
Box 3 Gift as exaggeration
I think saying it’s a gift is over-egging it, really. . .If you were to give your little ﬁnger it might be a gift
(Woman with cancer)
No, I don’t feel that I’m giving a gift. I just feel like I’m helping society (Woman, healthy volunteer)
To me if I give a monetary donation to help research, yes, that’s a gift, but if I’m giving a body part or
something like that, I don’t see that as being a gift. I think that’s something altogether diﬀerent (Man with
MND)
Bizzarely I think it’s a bit of an honour, really. I wouldn’t call it a gift. I don’t think it is [um] - I mean if
that’s, if that hits some people’s buttons, great. It’s just a “why wouldn’t you?” It’s a more naturally “yes”
thing than “no” thing (Woman, healthy volunteer)
If I’m sitting here and someone comes along and says, you know, “Give us a few phials of your blood
because we might be able to do something with it”, I’m just not going to think twice about it. It’s not a
gift (Man with MND)
Never thought of it in that concept [gift]. No, it’s not really the way I’ve thought of it. It’s a, [um] I am
[pause] - I probably view my body quite mechanically in that it’s all quite renewable. None of your body
is more than, what is it, ﬁve years old? And, [um] you know, tissue, odd bits, pint of blood here, whatever,
is, [um] somebody’s got a very good use for it. Well, I’ve had a very good use for it over the years (Man
with hepatitis C virus)
813Biosamples as gifts?, L Locock and A-M R Boylan
ª 2015 The Authors. Health Expectations Published by John Wiley & Sons Ltd.
Health Expectations, 19, pp.805–816
Tutton31 (p 537) contrasts blood sample
donation for his DNA study in Orkney with
blood donation for transfusion and concludes
that there is a diﬀerence between:
. . .the ‘corporeal’ economy of blood transfusion,
in which the blood itself is of immense value and
is used to assist someone in emergency medical
need, with the informational economy of
research, in which blood is merely an easy way
of getting to the DNA.
This distinction resonates with our ﬁndings
and helps explain why ‘gift’ can seem a trou-
bling or inappropriate word for biosamples.
The gift – the value – is in the giving, in the
collective contribution to research, rather than
in the sample itself. Focusing on the value of
participation and the information derived
rather than the value of the physical sample
might have more intuitive appeal to potential
participants. Perhaps this is not limited to
biobanking, but could also be extended to
other types of clinical research, including clini-
cal trials.
Practical implications arising from this study
are that we should avoid the term ‘gift’ in commu-
nicating with patients and seeking consent for
donation, given that it holds such diﬀerent mean-
ing for diﬀerent people and therefore oﬀers little
utility in representing participants’ views. Govern-
ing bodies should exercise caution when setting
discourses around donation, whilst recognizing
that the public holds positive attitudes towards
helping others and donating biosamples.
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Box 4 Urine contrasted with blood
The reflections of this woman who donated blood and urine samples during a high-risk pregnancy indicate the different
values people ascribe to waste products (e.g. urine) versus blood:
Interviewer There is some literature around the giving of tissue and blood samples as a kind of gift. . .. Does
‘gift’ sound the right sort of terminology for giving blood and urine samples to you?
[um] Not urine. [laughs] Because I can’t imagine that would be, anyone would want to make
any use of that. [um] I don’t. Yeah. [laughs] ‘Hello, happy birthday’. I do think with blood - I
mean I’m, because I’ve had a platelet transfusion in the past I’m no longer allowed to, I’m no
longer qualiﬁed to give blood. [um] I do think blood is a gift. I’m not so sure about other
bodily ﬂuids being gifts. [laughs] [um] But, yeah, no, deﬁnitely, blood is deﬁnitely a gift if . . .
Interviewer Mm. Even if it’s for research purposes?
I - yeah, I don’t - yeah, I don’t see why not. I think because I’m always amazed at how much
information they get out of how little. . .With my last two pregnancies - I mean, there was
blood taken all the time, every time. And they’re like, ‘Oh, you know, out of this they’ll take
like a hundred diﬀerent things’. And I think it is such a, for such a little thing to be able to
gain so much information is invaluable.
Although this woman made fun of the notion of urine being handed over as a birthday present, she could still see the
importance of urine for research. For her, it was thus consistent to see the research value of a sample at the same time as
laughing at the incongruity of an image of a ‘gift’ of urine. She went on to say:
Saying it’s a waste product is quite true. But I mean, in my case, yeah, urine shows up a massive amount
of information. [um] Probably not as much as blood but, yeah, I suppose there is just something associ-
ated with, “Here, have my urine,” [laughs] “and do something with it.” But, yes, I suppose as a source of
information. . ..
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